(Verdict Medical Devices) U.S.-based TransEnterix has purchased Israel-based Medical Surgery Technologies (MST). MST has developed software that will add advanced surgical image analytics technology capabilities to TransEnterix's Senhance digital laparoscopy platform. TransEnterix CEO Todd Pope said the addition of MST technology "will increase the effectiveness of surgeons, making procedures quicker and less error-prone, leading to better outcomes for the patient."
2018-09-28 00:00:00Full ArticleBACK Visit the Daily Alert Archive